Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5455/JPMA.16 http://scihub22266oqcxt.onion/10.5455/JPMA.16 32515380!�!32515380 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32515380.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Pak+Med+Assoc 2020 ; 70(Suppl 3) (5): S83-S86 Nephropedia Template TP {{tp|p=32515380|t=2020. Endocrine vigilance in COVID-19 |pdf=|usr=}}{{32515380}} gab.com Text Endocrine vigilance in COVID-19 JO: J Pak Med Assoc http://www.kidney.de/pget.php?&tw=1&pmid=32515380 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for a pandemic that emerged in December 2019. Heterogeneous clinical forms are described from asymptomatic to severe hypoxaemic acute respiratory syndrome with multisystem organ failure. The impact of this coronavirus disease 2019 on the endocrine glands remains unknown. However, the results of previous studies on viruses from the same family allow us to write proposals for patients followed for chronic endocrine diseases. Currently, if these subjects are infected with SARS-CoV-2, they must not stop their treatment. In some cases, hormone replacement doses have to be increased. In case of worsening clinical signs, hormonal biological monitoring must be done. This article will be helpful for improving the management of chronic endocrine diseases that could affect thyroid, adrenals, gonads and pituitary gland functions. Proposals could be applied in COVID-19 infected subjects or in those who have been in contact with COVID-19 infected people. Twit Text FOAVip Endocrine vigilance in COVID-19 ????J Pak Med Assoc http://www.kidney.de/pget.php?&tw=1&pmid=32515380 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32515380 #FOAvip English Wikipedia <ref>{{Cite pmid|32515380}}</ref> Endocrine vigilance in COVID-19 #MMPMID32515380 Velayoudom FL; Alwis Wijewickrama PS; Ranathunga HI; Somasundaram N J Pak Med Assoc 2020[May]; 70(Suppl 3) (5): S83-S86 PMID32515380show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for a pandemic that emerged in December 2019. Heterogeneous clinical forms are described from asymptomatic to severe hypoxaemic acute respiratory syndrome with multisystem organ failure. The impact of this coronavirus disease 2019 on the endocrine glands remains unknown. However, the results of previous studies on viruses from the same family allow us to write proposals for patients followed for chronic endocrine diseases. Currently, if these subjects are infected with SARS-CoV-2, they must not stop their treatment. In some cases, hormone replacement doses have to be increased. In case of worsening clinical signs, hormonal biological monitoring must be done. This article will be helpful for improving the management of chronic endocrine diseases that could affect thyroid, adrenals, gonads and pituitary gland functions. Proposals could be applied in COVID-19 infected subjects or in those who have been in contact with COVID-19 infected people. |*Betacoronavirus[MESH] |*Endocrine System Diseases/complications/therapy[MESH] |COVID-19[MESH] |Chronic Disease[MESH] |Coronavirus Infections/*complications[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications[MESH] |Risk Factors[MESH]Endocrine vigilance in COVID-19 (epmc).pdf DeepDyve Pubget Overpricing